• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Urine Test for Parkinson’s Disease

      Urine Test for Parkinson’s Disease

      Investigating Bacterial Motion for New Treatment Strategies

      Investigating Bacterial Motion for New Treatment Strategies

      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      siRNA as a COVID-19 Treatment

      siRNA as a COVID-19 Treatment

    • Radiology
      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

      Implanted Ultrasound Lets Chemo Access Brain

      Implanted Ultrasound Lets Chemo Access Brain

      Wearable Ultrasound Measures Tissue Stiffness Under Skin

      Wearable Ultrasound Measures Tissue Stiffness Under Skin

      Brain Decoder Spells Out Thoughts

      Brain Decoder Spells Out Thoughts

    • Cardiology
      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

      Pencil-on-Paper Wearable Sensor

      Pencil-on-Paper Wearable Sensor

      Cell Culture Chamber Mimics Mechanical States of Disease

      Cell Culture Chamber Mimics Mechanical States of Disease

      Chest Wearable Provides Key Heart Measurements

      Chest Wearable Provides Key Heart Measurements

    • Surgery
      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

      Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

      Soft Robotic Electrode Enables Minimally Invasive Placement

      Soft Robotic Electrode Enables Minimally Invasive Placement

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

    • Nanomedicine
      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Temperature Feedback for Prosthetic Limbs

      Temperature Feedback for Prosthetic Limbs

      Brain Decoder Spells Out Thoughts

      Brain Decoder Spells Out Thoughts

      Knitted Glove Massages the Hand to Treat Edema

      Knitted Glove Massages the Hand to Treat Edema

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Middle East and Turkey Immune Thrombocytopenic Purpura (ITP) Treatment Drugs Market to Reach a Valuation of USD 185 Mn by 2027 At a CAGR of 4.0%

February 25th, 2020 Coherent Market Insights Releases

Middle East and Turkey Immune Thrombocytopenic Purpura (ITP) Treatment Drugs Market, by Drug Type (Steroid, Immunoglobulins, Thrombopoietin Receptor Agonist and Others, By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and By Country (Turkey, Israel, Egypt, Saudi Arabia, UAE, and Rest of Middle East) was valued at US$  82.23 million in 2019 and is projected to exhibit a CAGR of 4.0% over the forecast period (2019 – 2027), as highlighted in a new report published by.

Increasing number of clinical trials, rising government support and healthcare spending for development of better medical facilities in the Middle East are the major factors that are expected to drive growth of the Middle East and Turkey immune Thrombocytopenic Purpura (ITP) Treatment Drugs Market.

Request Free PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/3171

Various organizations are focusing on developing new solutions for treatment of immune thrombocytopenic purpura which is expected to favor growth of the Middle East and Turkey immune Thrombocytopenic Purpura (ITP) Treatment Drugs Market. For instance, in November 2018, Novartis Pharmaceuticals started a clinical trial to study the ability of Eltrombopag to induce sustained treatment-free remission in ITP subjects who relapsed or failed to respond to initial steroids treatment. It is an interventional clinical trial with more than 100 participants. The clinical trial is in phase 2 and is expected to complete in May 2022.

Furthermore, launch of new healthcare plans and programs is expected to fuel growth of the Middle East and Turkey immune thrombocytopenic purpura drugs market. For instance, in 2010, UAE Vision 2021 was launched by the Prime Minister of the U.A.E. As part of the Vision 2021 plan, UAE is aiming to provide ‘world-class healthcare’ in the UAE by pushing for greater preventive measures to counter lifestyle-related diseases and rare diseases by implementing an accelerated drug registration system, and including health as a key sector within the country’s wider innovation strategy.

Increasing healthcare expenditure in the UAE is expected to boost the market growth over the forecast period. For instance, according to the Export Gov., 2019 report, UAE’s healthcare expenditure was US$ 13.7 billion in 2018, and it is expected to reach US$ 18.3 billion by 2023. Furthermore, in 2015, the UAE government launched a new health insurance scheme in Dubai. Under this scheme, 130,000 people get healthcare at 23 private hospitals and more than 500 medical clinics in and around Dubai.

Browse 20 Market Data Tables and 21 Figures spread through 114 Pages and in-depth TOC on “Middle East and Turkey Immune Thrombocytopenic Purpura (ITP) Treatment Drugs Market, By Drug Type (Steroid, Immunoglobulins, Thrombopoietin Receptor Agonist and Others, By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Country (Turkey, Israel, Egypt, Saudi Arabia, UAE, and Rest of Middle East) – Global Forecast to 2027”

To know the latest trends and insights related to the Middle East and Turkey immune Thrombocytopenic Purpura (ITP) Treatment Drugs Market Press Release, click the link below: https://www.coherentmarketinsights.com/press-release/middle-east-and-turkey-immune-thrombocytopenic-purpura-treatment-drugs-market-2572

Moreover, many pharmaceutical companies are focusing on entering the Middle East region, which is a highly untapped region. For instance, in March 2018, Felix Pharmaceuticals Industries announced the construction of a pharmaceutical plant and logistics center at the Salalah Free Zone in Oman. The company invested US$ 365 million for construction of the plant. The project is implemented in three stages, starting in 2018 and ending in 2021.

Key Takeaways of the Middle East and Turkey Immune Thrombocytopenic Purpura (ITP) Treatment Drugs Market:

  • The Middle East and Turkey immune Thrombocytopenic Purpura (ITP) Treatment Drugs Market is expected to expand at a CAGR of 4.0% during the forecast period (2019–2027) owing to increasing government support, clinical trials, and healthcare expenditure.
  • Among drug types, the steroid segment is expected to hold major revenue share in 2027. Various organizations are focusing on R&D activities to develop immune thrombocytopenic purpura drugs. Ongoing research has analyzed the efficacy and safety of high-dose dexamethasone and prednisone for treatment of patients who have been newly diagnosed with ITP. The corticosteroid drug has not received approval in any of the Middle East countries for treating ITP.
  • Major players operating in the Middle East and Turkey Immune Thrombocytopenic Purpura (ITP) Treatment Drugs Market include Amgen Inc., Octapharma AG, Novartis AG, Swedish Orphan Biovitrum AB, and Rigel Pharmaceuticals, Inc.

Detailed Segmentation:

  • Middle East and Turkey Immune Thrombocytopenic Purpura (ITP) Treatment Drugs Market, By Drug Type:
    • Steroid
    • Immunoglobulins
    • Thrombopoietin Receptor Agonist
    • Others
  • Middle East and Turkey Immune Thrombocytopenic Purpura (ITP) Treatment Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Middle East and Turkey Immune Thrombocytopenic Purpura (ITP) Treatment Drugs Market, By Country:
    • Turkey
      • By Drug Type:
        • Steroid
        • Immunoglobulins
        • Thrombopoietin Receptor Agonist
        • Others
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Israel
      • By Drug Type:
      • By Distribution Channel:
    • Egypt
      • By Drug Type:
      • By Distribution Channel:
    • Saudi Arabia
      • By Drug Type:
      • By Distribution Channel:
    • UAE
      • By Drug Type:
      • By Distribution Channel:
    • Rest of Middle East
      • By Drug Type:
      • By Distribution Channel:
  • Company Profiles
    • Amgen Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Octapharma AG
    • Novartis AG
    • Swedish Orphan Biovitrum AB
    • Rigel Pharmaceuticals, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
sales@coherentmarketinsights.com

U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737

Sign up and submit a press release

Sponsored

Packaging Compliance Labs (PCL) Celebrates Site Expansion in Grand Rapids, MI

Novel Approach to Assessing Lung Function Enables Improved Detection, Diagnosis and Treatment Decisions in Subject Exposed to Military Burn Pits

U.S. Patent Office Grants Additional Patent Protection For  Exoskeleton Focal-Force Angioplasty Platform

U.S. Patent Office Grants Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

New AI-Powered Voice Controls Streamline Ultrasound Imaging with All Clarius Handheld Systems

New AI-Powered Voice Controls Streamline Ultrasound Imaging with All Clarius Handheld Systems

interviews & reviews
Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email